| abstract |
The invention relates to the use of the MAL protein as a novel marker and molecular target in epithelial tumours and other human pathologies. More specifically, the invention relates to the use of the detection of the MAL protein as a marker for diagnosis and prognosis purposes for tumours or other pathologies that affect epithelial cells, T lymphocytes, mast cells, myelin-forming cells or other cell types which normally express the MAL protein. |